Late-stage drug failures drive toxicology testing market growth
Drug Discovery World
FEBRUARY 26, 2024
billion by 2030, with a growth rate of 10.2%. Factors such as an increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid revenue generation for the market.
Let's personalize your content